4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-034765
Options or other derivatives
- Director acquired 26,150 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ryan David P. Director | 2022-11-01 | Grant or award · Stock Option (Right to Buy) | +26,150 | 26,150 | D | ||
Loading xslF345X03/doc4.xml…